Navigation Links
Neovasc Inc. Reports Second Quarter 2009 Financial Results
Date:8/19/2009

the six months ended June 30, 2009, sales and marketing expenses were $466,568, compared to $1,534,995 for the same period in 2008, a 70% decrease. The company terminated its direct sales force for its catheter products in the fourth quarter of 2008 and will continue to minimize sales and marketing costs while it focuses on growing its business-to-business revenue streams. General and administrative expenses for the three and six months ended June 30, 2009 were $659,004 and $1,409,833, respectively, as compared to $779,363 and $1,317,648 for the comparable periods in 2008, a decrease of 15% for the three-month period and an increase of 7% for the six-month period. Substantially all of the increase in general and administrative expenses in the six-month period reflects an increase in stock-based compensation charges. Product development and clinical trial expenses were $864,702 and $1,741,482 respectively, for the three and six months ended June 30, 2009, as compared to $414,958 and $1,036,703 for the same periods in 2008, representing increases of 108% and 68% respectively. Product development expenditures to advance the Neovasc Reducer CE mark regulatory submission and the final Metricath Gemini PMA submission contributed to the increase.

Net Losses

The consolidated net loss for the three and six months ended June 30, 2009 was $1,330,451 and $3,076,691, or $0.05 and $0.14 basic loss per share, as compared to a net loss of $1,915,673 and $3,657,248, or $0.34 and $0.66 basic loss per share for the comparable periods in 2008. The decrease in net loss year-on-year reflects the company's increased revenues and decreased losses.

Liquidity and Capital Resources

The company finances its operations and capital expenditures with cash generated from operations, lines of credit, long-term debt and equity financings. At June 30, 2009, the company had cash and cash equivalents of $1,340,471, as compared to cash
'/>"/>

SOURCE Neovasc Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
2. Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results
3. Neovasc Announces Agreement With LeMaitre Vascular for Exclusive Distribution Rights to its Biological Vascular Strips
4. Neovasc Receives CE Mark Approval for Peripatch(TM) Aegis Staple Line Reinforcement Product
5. Neovasc to Raise $2 Million in Non-Brokered Private Placement
6. Neovasc Inc. Reports Year 2008 Financial Results
7. Neovasc Completes $2 Million Non-Brokered Private Placement
8. Positive Results for Ophthotechs Novel Therapy for Wet AMD - Study of Anti-PDGF and Anti-VEGF Therapy Shows Significant Neovascular Regression and Enhanced Visual Outcome
9. Neovasc Inc. Reports First Quarter 2009 Financial Results
10. Neovasc Inc. Postpones Plans for U.S. Listing to Focus Funds on Commercializing Its Reducer Device for Refractory Angina
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... Obese youths have a nearly six fold risk ... ,22 000 young people from the PEP Family ... Professor Peter Schwandt from Germany. , Professor Schwandt ... children and adolescents is continuing to rise in ... considered a driving force for cardiovascular disease, we ...
(Date:8/31/2014)... California (PRWEB) August 31, 2014 ... environmentally harmful disc brake dust at the source ... , Problem: Millions of vehicles globally emit brake ... ingredients in the friction materials (disc brake pads) ... the nations’ water systems. For example, copper impairs ...
(Date:8/31/2014)... 2014 Priya Khan, Director of ... concern over misinformation about weight-loss supplements saying, “Consumers ... often, misleading information being propagated by unscrupulous companies ... are weighing in on the subject. , NutriGold’s ... and especially weight-loss products and to provide them ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 To make ... supplement brand they can trust, NutriGold is shipping complimentary ... A form has been set up to make taking ... , According to Priya Khan, Director of Research ... customers purchase one of our products, they are entrusting ...
(Date:8/31/2014)... 2014 “Prohibition is our history,” ... our future: the present ~ that’s political.” , ... , new on the Bryan William Brickner Blog, ... system (CS) modulation and homeostasis - including one ... use. The Publius CS update includes: heteromerization ...
Breaking Medicine News(10 mins):Health News:Obese youths have a nearly 6 fold risk of hypertension 2Health News:CBPModular Technology with Global Patent Coverage Solves Vehicle Wheel Brake Dust Problem 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Homeostasis: Publius’ Alcohol Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... of Michigan evolutionary biologist Jianzhi "George" Zhang, has uncovered ... a sex determiner in honey bees. These novel inputs ... methods to breed honeybees, who are effective pollinators of ... findings of Zhang and collaborators are published in a ...
... to pain.In the study conducted on rats, the development// ... expression of that particular gene after a nerve injury ... of new painkillers. ,"Studies in volunteers showed ... variant that protects them from pain somewhat, and three ...
... disease is to be resumed and researchers from Southampton University ... ,The progress of the disease was supposed to be reversed ... the disease. But during the second phase of the trial, ... the study was brought to a halt for safety ...
... plastic and reconstructive surgeon has been given the go-ahead ... the Royal Free Hospital, London to select four patients ... College of Surgeons has called for caution with leading ... surgery promises to transform the lives of hundreds of ...
... implanted in 65,000 dogs in Shanghai to improve canine management ... at curbing// rabies in provinces of Yunnan and Shandong drew ... ID number. To access information about the dog - photo, ... have to access the ID number. ,Chip developer ...
... Gleneagles Hospitals has asked the West Bengal government for 10 ... here for setting up// a Rs.1.5 billion institute. ... research in the medical field, said V. Satyanarayana Reddy, CEO, ... the government to identify and hand over a site for ...
Cached Medicine News:Health News:Breeding success by delving into the honey bee sex gene 2Health News:Breeding success by delving into the honey bee sex gene 3Health News:Gene determines pain threshold... 2Health News:Alzheimer's Vaccine- A Realistic Prospect 2Health News:Green Signal given to Full-Face Transplants 2Health News:Green Signal given to Full-Face Transplants 3
(Date:8/30/2014)... , Aug. 30, 2014  Boston Scientific ... NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical ... trial investigating vagus nerve stimulation (VNS) for the ... Ph.D., Professor of Therapeutics and Cardiology and Director ... National de la Sante et de la Recherche ...
(Date:8/30/2014)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... ultrasound system designed to enable global hospitals and health ... and cost pressures. Making its debut at the  European ... Barcelona this week, Affiniti provides innovative technology ... resources deliver high quality patient care. ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... Osteotech, Inc. (Nasdaq: OSTE ), a leader in the ... the Company,s first quarter ended March 31, 2010 financial ... May 10, 2010 .  The management team of Osteotech will host ... , at 9:00 a.m. (EDT) to discuss the Company,s ...
... Doctora Aliza, editor in chief of VidaySalud.com and expert health commentator for the ... Latino Legislative Caucus during a special Assembly floor session at the California Capitol ... , (Photo: ... "Doctor Aliza ...
Cached Medicine Technology:Osteotech Announces First Quarter 2010 Financial Results Release and Conference Call 2Latino Spirit Award For VidaySalud.com's Doctora Aliza 2
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Subretinal Aspiration Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 6.5mm, 27g (0.40); Angled at 60°, 2.5mm from Tip....
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Medicine Products: